CCL18 and nonpapillary renal cell carcinoma: CCL18 expressed from TAMs plays a critical role in immune and inflammation responses, and its receptor CCR8 marks suppressive Treg cells within the tumor [48] suggesting the immunosuppressive potential of the CCL18-CCR8 axis in bone metastatic ccRCC.